Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Conjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational study.

Arroyo R, Sempere AP, Ruiz-Beato E, Prefasi D, Carreño A, Roset M, Maurino J.

BMJ Open. 2017 Mar 8;7(3):e014433. doi: 10.1136/bmjopen-2016-014433.

2.

Five cases of acrometastasis to the hand from a carcinoma and review of the literature.

Muñoz-Mahamud E, Combalia A, Carreño A, Arandes JM.

Hand Surg Rehabil. 2017 Feb;36(1):12-16. doi: 10.1016/j.hansur.2016.10.211. Epub 2016 Dec 1.

PMID:
28137435
3.

Clinical translation of a mesenchymal stromal cell-based therapy developed in a large animal model and two case studies of the treatment of atrophic pseudoarthrosis.

Prat S, Gallardo-Villares S, Vives M, Carreño A, Caminal M, Oliver-Vila I, Chaverri D, Blanco M, Codinach M, Huguet P, Ramírez J, Pinto JA, Aguirre M, Coll R, Garcia-López J, Granell-Escobar F, Vives J.

J Tissue Eng Regen Med. 2016 Sep 29. doi: 10.1002/term.2323. [Epub ahead of print]

PMID:
27684058
4.

Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.

Gracia M, Betriu À, Martínez-Alonso M, Arroyo D, Abajo M, Fernández E, Valdivielso JM; NEFRONA Investigators.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):287-96. doi: 10.2215/CJN.01240215. Epub 2015 Dec 14.

5.

Apoptotic induction by pinobanksin and some of its ester derivatives from Sonoran propolis in a B-cell lymphoma cell line.

Alday E, Valencia D, Carreño AL, Picerno P, Piccinelli AL, Rastrelli L, Robles-Zepeda R, Hernandez J, Velazquez C.

Chem Biol Interact. 2015 Dec 5;242:35-44. doi: 10.1016/j.cbi.2015.09.013. Epub 2015 Sep 11.

PMID:
26367700
6.

Registered report: Interactions between cancer stem cells and their niche govern metastatic colonization.

Incardona F, Doroudchi MM, Ismail N, Carreno A, Griner E, Anna Lim M; Reproducibility Project: Cancer Biology.

Elife. 2015 Jun 18;4:e06938. doi: 10.7554/eLife.06938.

7.

Syndrome in question. Costello syndrome.

Peixoto IL, Carreno AM, Prazeres VM, Chirano CA, Ihara GM, Akel PB.

An Bras Dermatol. 2014 Nov-Dec;89(6):1005-6.

8.

Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study.

Arroyo D, Betriu A, Martinez-Alonso M, Vidal T, Valdivielso JM, Fernández E; investigators from the NEFRONA study.

BMC Nephrol. 2014 Oct 18;15:168. doi: 10.1186/1471-2369-15-168.

9.

[Adherence to patients antidepressant treatment and the factors associated of non-compiance].

Párraga Martínez I, López-Torres Hidalgo J, del Campo del Campo JM, Villena Ferrer A, Morena Rayo S, Escobar Rabadán F; en representación del Grupo ADSCAMFYC.

Aten Primaria. 2014 Aug-Sep;46(7):357-66. doi: 10.1016/j.aprim.2013.11.003. Epub 2014 Apr 3. Spanish.

10.

Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study.

Betriu A, Martinez-Alonso M, Arcidiacono MV, Cannata-Andia J, Pascual J, Valdivielso JM, Fernández E; Investigators from the NEFRONA Study.

Nephrol Dial Transplant. 2014 Jul;29(7):1415-22. doi: 10.1093/ndt/gfu038. Epub 2014 Feb 28.

PMID:
24586070
11.

[Validation of Questionnaire "ESTA": designed to assess the satisfaction with antidepressant treatment. Spain].

López-Torres Hidalgo J, López Gallardo Y, Párraga Martínez I, del Campo del Campo JM, Villena Ferrer A, Morena Rayo S; Grupo ADSCAMFYC.

Rev Esp Salud Publica. 2013 Nov-Dec;87(6):615-25, 627, quiz; 626. doi: 10.4321/S1135-57272013000600006. Spanish.

12.

Profilin sensitisation in a Mediterranean population.

Huertas AJ, Carreño A, Mérida C, Pajarón-Fernández MJ, Ramírez-Hernández M, Carnés J.

Allergol Immunopathol (Madr). 2014 Sep-Oct;42(5):387-94. doi: 10.1016/j.aller.2013.09.005. Epub 2014 Jan 8.

PMID:
24411096
13.

Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.

Cabrera CM, Urra JM, Carreño A, Zamorano J.

Scand J Immunol. 2013 Sep;78(3):306-12. doi: 10.1111/sji.12088.

14.

Nail apparatus melanoma: a diagnostic opportunity.

Carreño AM, Nakajima SR, Pennini SN, Candido Junior R, Schettini AP.

An Bras Dermatol. 2013 Mar-Apr;88(2):268-71. doi: 10.1590/S0365-05962013000200017.

15.

Once-monthly pegylated epoetin Beta versus darbepoetin alfa every two weeks in renal transplant recipients: a randomized trial.

Campistol JM, Carreño A, Morales JM, Pallardó L, Franco A, Navarro D, Grinyó JM, Montenegro J, Sánchez Fructuoso AI, Romero R, Guirado L, Arias M; TIVOLI Study Group.

Transplantation. 2013 Jan 27;95(2):e6-e10. doi: DOI: 10.1097/TP.0b013e3182782f3a. No abstract available.

PMID:
23325012
16.

(E)-2-{[(2-Amino-pyridin-3-yl)imino]-meth-yl}-4,6-di-tert-butyl-phenol.

Carreño A, Ladeira S, Castel A, Vega A, Chavez I.

Acta Crystallogr Sect E Struct Rep Online. 2012 Aug 1;68(Pt 8):o2507-8. doi: 10.1107/S1600536812032060. Epub 2012 Jul 21.

17.

Mycophenolate as induction therapy in lupus nephritis with renal function impairment.

Rivera F, Fulladosa X, Poveda R, Frutos MA, García-Frías P, Ara J, Illescas L, López-Rubio E, Mérida E, Carreño A, Ballarín J, Fernández-Juárez G, Baltar J, Ramos C, Pons S, Oliet A, Vigil A, Praga M, Segarra A; Spanish Group for the Study of Glomerular Disease (GLOSEN).

Am J Nephrol. 2012;35(5):424-33. doi: 10.1159/000337916. Epub 2012 Apr 20.

PMID:
22517244
18.

Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study.

de la Sierra A, Banegas JR, Segura J, Gorostidi M, Ruilope LM; CARDIORISC Event Investigators.

J Hypertens. 2012 Apr;30(4):713-9. doi: 10.1097/HJH.0b013e328350bb40.

PMID:
22306850
19.

Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia.

Navas MC, Suarez I, Carreño A, Uribe D, Rios WA, Cortes-Mancera F, Martel G, Vieco B, Lozano D, Jimenez C, Gouas D, Osorio G, Hoyos S, Restrepo JC, Correa G, Jaramillo S, Lopez R, Bravo LE, Arbelaez MP, Scoazec JY, Abedi-Ardekani B, Santella RM, Chemin I, Hainaut P.

Hepat Res Treat. 2011;2011:582945. doi: 10.1155/2011/582945. Epub 2011 Oct 31.

20.

[The OASIS study: therapeutic management of acromegaly in standard clinical practice. Assessment of the efficacy of various treatment strategies].

Luque-Ramírez M, Carreño A, Alvarez Escolá C, del Pozo Picó C, Varela da Costa C, Fajardo Montañana C, Gilabert M, Webb S; Grupo Español del estudio OASIS.

Endocrinol Nutr. 2011 Nov;58(9):478-86. doi: 10.1016/j.endonu.2011.09.002. Epub 2011 Oct 26. Spanish.

PMID:
22032858

Supplemental Content

Loading ...
Support Center